◈ Nootpedia

This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Milk Thistle

Silymarin (the flavonolignan complex from Silybum marianum seeds, dominated by silybin) is the most studied herbal hepatoprotectant on the planet, with 200+ trials, a 2024 meta-analysis of 26 RCTs …

Aliases (1)
MILK THISTLE
TYPICAL DOSE
Standardization is critical
ROUTE
—
CYCLE
—
STORAGE
—

Overview

What is Milk Thistle?

Silymarin (the flavonolignan complex from Silybum marianum seeds, dominated by silybin) is the most studied herbal hepatoprotectant on the planet, with 200+ trials, a 2024 meta-analysis of 26 RCTs (n=2,375) showing consistent ALT/AST/histology improvements in NAFLD/NASH, and an IV formulation (Legalon-SIL) that is the global gold-standard antidote for Amanita phalloides (death-cap) poisoning. Mechanism is membrane stabilization + glutathione upregulation + Kupffer-cell suppression — not CYP induction or "detox." For Dylan (20yo MMA athlete on a clean V4 supplement-heavy stack, no PEDs, no alcohol, low chronic pain-med use), it's an OPTIONAL-ADD with medium confidence: marginal preventive value at baseline, but high-value as cycle-support insurance if he ever runs orals, SARMs, or starts heavy NSAID use post-training. Standardized 80% silymarin extract at 420 mg/day in 3 divided doses with meals is the canonical protocol; Siliphos phytosome (250 mg ≈ 600 mg standard) is the bioavailability upgrade. Buy when bloodwork (June 2026 panel) shows ALT/AST trending toward upper limit of normal; otherwise skip or keep in the medicine cabinet as PRN.

Research Indications

Most Effective

Take with food

fat enhances absorption ~2-fold even for plain silymarin.

Peptide Interactions

NAC (N-acetylcysteine, 600-1200 mg/day):
Synergistic

The classic "liver stack" pairing. NAC supplies cysteine (the rate-limiting GSH precursor); silymarin upregulates the synthesis enzyme. Mechanistic synergy c…

TUDCA (tauroursodeoxycholic acid, 250-500 mg/day):
Synergistic

Complementary mechanism — TUDCA is a hydrophilic bile acid that protects against cholestasis and ER stress, while silymarin handles oxidative + inflammatory …

Alpha-lipoic acid (ALA, 300-600 mg/day):
Synergistic

Universal antioxidant that regenerates both vitamin C and vitamin E and supports mitochondrial function in hepatocytes. Pairs well with silymarin's membrane-…

Phosphatidylcholine (PC) / lecithin:
Synergistic

PC is a structural component of hepatocyte membranes. Realsil-style formulations exploit this — silybin + PC together is more effective than silybin alone.

Vitamin E (mixed tocopherols, ~400 IU/day):
Synergistic

Membrane-protective antioxidant; complements silymarin's role. The Realsil formulation includes vitamin E for this reason. Note: high-dose alpha-tocopherol m…

Choline (in CDP-choline / citicoline or eggs):
Synergistic

Sufficient choline is required for VLDL packaging and prevents fatty liver. Dylan already takes citicoline in V4 — covered.

Curcumin (with piperine or phytosome):
Synergistic

Anti-inflammatory; mild hepatoprotective in its own right. Pairs reasonably with silymarin in NAFLD-targeting stacks.

Berberine (500 mg b.i.d.-t.i.d.):
Synergistic

Insulin-sensitizing + lipid-lowering; complements silymarin in metabolic-syndrome / NAFLD context.

Cyclosporine, tacrolimus
Avoid

(immunosuppressants with narrow therapeutic index): silymarin's mild CYP3A4 inhibition could elevate levels. Avoid or monitor levels closely if combined.

Raltegravir, indinavir
Avoid

(HIV protease/integrase inhibitors): in vitro evidence of interaction; clinical significance debated. Defer to HIV specialist.

High-dose hormonal contraceptives + concurrent CYP3A4 inducers:
Avoid

silymarin alone doesn't reduce contraceptive efficacy, but in combination with strong CYP3A4 inducers the interaction landscape gets complicated. Most users:…

What to Expect

  • Week 1
    Tolerability and dose-response.
  • Week 2-4
    Early effect window.
  • Week 4-8
    Peak benefit assessment.
  • Week 8+
    Cycle decision point.

Side Effects & Safety 4

Side Effects

  1. 1None — milk thistle is one of the most well-tolerated supplements in the herbal pharmacopeia.
  2. 2GI upset: mild bloating, loose stools, abdominal discomfort, gas. Resolves with food, lower dose, or discontinuation. ~5-10% of users.
  3. 3Mild laxative effect: silymarin stimulates bile flow, which is mildly laxative. Sometimes useful for users with constipation; problematic if it tips into loose stools.
  4. 4Headache: rare, mechanism unclear, usually resolves.

When to Stop

  • Allergic reaction in Asteraceae-sensitive individuals. *Silybum marianum* is in the Asteraceae (daisy/composite) family along with ragweed, chrysanthemums, marigolds, and chamomile. Cross-reactivity is documented in the small subset of users with severe Asteraceae allergy. Reaction range: mild urticaria → angioedema → (very rare) anaphylaxis. If a user has known ragweed/chrysanthemum allergy, start with a microdose and observe.
  • Hypoglycemia in diabetics: silymarin's insulin-sensitizing effect can mildly potentiate hypoglycemic agents (metformin, sulfonylureas, insulin). Monitor glucose if recently started.
  • Estrogenic activity (theoretical): silymarin has weak phytoestrogenic activity in vitro. Clinical relevance at supplement doses is minimal but caution in estrogen-sensitive conditions (some breast cancers, endometriosis) is reasonable.
  • First 2 weeks: GI tolerance — if loose stools or bloating, drop dose to 140 mg/day for a week, then titrate up.
  • First month if on antidiabetic medication: glucose monitoring more frequently.
  • Any time, lifetime: if rash, swelling, breathing difficulty → stop immediately, treat as allergic reaction.

References

Li S et al. 2024 — Administration of silymarin in NAFLD/NASH: systematic review + meta-analysis (26 RCTs, n=2375)

pubmed.ncbi.nlm.nih.gov · 2024

strongest current indication; PMID 38579127.

View Study

Mengs U et al. 2012 — Legalon-SIL: antidote of choice for amatoxin poisoning

pubmed.ncbi.nlm.nih.gov · 2012

gold-standard *Amanita* antidote review; PMID 22352731.

View Study

Rambaldi A et al. 2007 — Cochrane: Milk thistle for alcoholic and/or hepatitis B/C liver diseases

pubmed.ncbi.nlm.nih.gov · 2007

null/limited hard-endpoint signal; PMID 17943794.

View Study

Loguercio C et al. 2012 — Silybin + phosphatidylcholine + vitamin E in NAFLD RCT (Realsil)

pubmed.ncbi.nlm.nih.gov · 2012

12-month NAFLD trial with histological endpoint; PMID 22343419.

View Study

Jaffar HM et al. 2024 — Silymarin pharmacological spectrum + therapeutic potential narrative review

pubmed.ncbi.nlm.nih.gov · 2024

mechanism synthesis; PMID 38726410.

View Study
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…
✎

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load ▸
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from Milk Thistle
TUDCA
OPTIONAL-ADD
Supplement
MEDIUM